Get the Stockscreener App
13.00
0.42%
0.05
Surgery Partners Inc stock is traded at $13.00, with a volume of 300.61K.
It is up +0.42% in the last 24 hours and down -13.31% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$12.95
Open:
$13.11
24h Volume:
300.61K
Relative Volume:
0.17
Market Cap:
$1.68B
Revenue:
$3.31B
Net Income/Loss:
$98.90M
P/E Ratio:
-21.20
EPS:
-0.6131
Net Cash Flow:
$195.60M
1W Performance:
-7.64%
1M Performance:
-13.31%
6M Performance:
-41.18%
1Y Performance:
-44.97%
1-Day Range:
$12.85
$13.23
1-Week Range:
$12.72
$14.19
52-Week Range:
$12.25
$24.60
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
13.00 | 1.68B | 3.31B | 98.90M | 195.60M | -0.6131 |
|
HCA
Hca Healthcare Inc
|
533.06 | 120.23B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
236.25 | 20.65B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.77 | 12.82B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
208.86 | 12.18B | 4.11B | 239.98M | 193.10M | 4.12 |
|
UHS
Universal Health Services Inc
|
185.28 | 11.39B | 16.08B | 1.20B | 1.06B | 17.82 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Resumed | JP Morgan | Neutral |
| Jul-28-25 | Resumed | BofA Securities | Buy |
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
Surgery Partners at Barclays Healthcare Conference: Strategic Plans Amid Challenges - Investing.com
Deals tracker: Elsevier to acquire Mytonomy - Modern Healthcare
Activist Ortelius pushes for board changes, asset sales at Surgery Partners - Seeking Alpha
Activist investor calls for Surgery Partners leadership change By Investing.com - Investing.com India
Ortelius Capital Management recently proposed a series of strategic adjustments for Surgery Partners, Inc., including a comprehensive overhaul of the board structure, the introduction of a new management team, and a systematic evaluation of the company’s - Bitget
Ortelius Delivers Open Letter To Surgery Partners Stockholders - TradingView
Ortelius Delivers Open Letter to Surgery Partners Stockholders - The Joplin Globe
Activist urges Surgery Partners to sell hospitals and raise billions - Stock Titan
Surgery Partners to Present at Barclays Healthcare Conference - National Today
Precision Trading with Surgery Partners Inc. (SGRY) Risk Zones - Stock Traders Daily
Surgery Partners, Inc. $SGRY Stock Position Decreased by Gabelli Funds LLC - MarketBeat
Burkhalter, Surgery Partners CHRO, sells $105k in shares - Investing.com Australia
Surgery Partners’ Webb sells $28,653 in shares By Investing.com - Investing.com India
Burkhalter, Surgery Partners CHRO, sells $105k in shares By Investing.com - Investing.com India
William Trenton Webb Sells 1,794 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
Marissa Brittenham Sells 8,785 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
David Doherty Sells 14,574 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
Jennifer Baldock Sells 10,082 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
Surgery Partners (NASDAQ:SGRY) CEO Sells $158,060.98 in Stock - MarketBeat
Baldock of Surgery Partners sells $138k in shares - Investing.com
Surgery Partners CFO Doherty sells $201,704 in shares By Investing.com - Investing.com UK
Surgery Partners CFO Doherty sells $201,704 in shares - Investing.com
Surgery Partners, Inc. to Present at Upcoming Investor Conference - marketscreener.com
Hear Surgery Partners’ Barclays healthcare presentation live online - Stock Titan
Outpatient Care Q4 2025: Mixed Earnings, Surgery Partners Revenue UpNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Outpatient & Specialty Care Stocks Q4 Highlights: Surgery Partners (NASDAQ:SGRY) - Finviz
Surgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Surgery Partners, Inc. Stock Plummets to New 52-Week Low at $12.25 - Markets Mojo
GABELLI & Co INVESTMENT ADVISERS INC. Lowers Holdings in Surgery Partners, Inc. $SGRY - MarketBeat
Surgery Partners Faces Weak Start with 21.85% Gap Down Amid Market Concerns - Markets Mojo
Day Trade: Is Surgery Partners Inc affected by consumer sentimentJuly 2025 Fed Impact & Stock Market Timing Techniques - baoquankhu1.vn
Assessing Surgery Partners (SGRY) Valuation After Recent Share Price Weakness And Undervalued Narrative - Sahm
TD Cowen Lowers Surgery Partners (NASDAQ:SGRY) Price Target to $20.00 - MarketBeat
SGRY Stock: TD Cowen Lowers Price Target to $20.00, Maintains Bu - GuruFocus
Analyst Expectations For Surgery Partners's Future - Benzinga
UBS Group Issues Pessimistic Forecast for Surgery Partners (NASDAQ:SGRY) Stock Price - MarketBeat
UBS Maintains 'Buy' Rating for Surgery Partners (SGRY), Lowers P - GuruFocus
UBS Adjusts Price Target on Surgery Partners to $21 From $29, Maintains Buy Rating - marketscreener.com
SGRY: Mizuho Lowers Price Target to $17, Maintains Outperform Ra - GuruFocus
Surgery Partners (NASDAQ:SGRY) Price Target Cut to $17.00 by Analysts at Mizuho - MarketBeat
Surgery Partners acquires dialysis access provider for $6B market By Investing.com - Investing.com Canada
Jefferies Maintains Buy on Surgery Partners (SGRY) March 2026 - Meyka
ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS - Finviz
Benchmark cuts Surgery Partners stock price target on weak guidance By Investing.com - Investing.com Canada
Jefferies cuts Surgery Partners stock price target on earnings reset By Investing.com - Investing.com Canada
Custom Surgical Partners & Ambulatory Strategies Unite: Decades of ASC Expertise - Newswise
Surgery Partners, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - marketscreener.com
Surgery Partners, Inc. Shareholders Are Encouraged to Reach - GlobeNewswire
RBC Cuts Price Target on Surgery Partners to $20 From $31, Keeps Outperform Rating - marketscreener.com
Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2025 Earnings Call Transcript - Insider Monkey
Surgery Partners (SGRY -12%): Weak Guidance, Q4 EBITDA Miss Drive Sell-Off - Trefis
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.16%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):